Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02690272
Other study ID # 2015-A00971-48
Secondary ID
Status Completed
Phase N/A
First received February 11, 2016
Last updated October 30, 2017
Start date February 29, 2016
Est. completion date September 11, 2017

Study information

Verified date October 2017
Source University Hospital, Angers
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The kidney transplant remains the privileged treatment of the terminal renal insufficiency. This care is complex for the patient both on a medical surgical plan and by the psychic reorganizations. Among the temporary contraindications of transplantation, us retrouvonsdes psychological reasons. The research work consists in highlighting the psychic mechanisms of the subjects awaiting kidney transplant.


Recruitment information / eligibility

Status Completed
Enrollment 33
Est. completion date September 11, 2017
Est. primary completion date August 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- 18 years old

- stade 4 or 5 renal insufficiency

- Registered on waiting list for a first kidney transplant

Exclusion Criteria:

- in ward

- Unsigned consent

- Already transplanted

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Psychic processes
Quantitative and qualitative aprroche of the psychic process

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Angers

Outcome

Type Measure Description Time frame Safety issue
Primary Measure of anxiety STAI-Y questionnaire with 20 items used to measure anxiety degree 6 months
Primary Measure of psychic representations around transplant ETA test: this test consists of an interview then the psychic projection through the drawing of 3 trees imagined by the patient and talking about him. 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT05913596 - The Safety and Efficacy of CD38 Monoclonal Antibody Monotherapy for CaAMR in Renal Transplantation N/A